Clinical trial
Endothelin-Receptor Blockade in Coronary Heart Disease
NCT00427232 · Medical University of Vienna, Other · Completed
Key facts
| NCT number | NCT00427232 |
|---|---|
| Title | Endothelin-Receptor Blockade in Coronary Heart Disease |
| Official title | Selective and Non-Selective Endothelin-Receptor Blockade in Coronary Artey Disease |
| Lead sponsor | Medical University of Vienna, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Coronary Vessels, Endothelins, Vascular Resistance |
| Intervention type | Drug |
| Interventions | BQ-123 and BQ-788 |
| Enrollment | 26 |
| Start date | May 1, 2003 |
| Completion | Aug 1, 2006 |
| First posted | Jan 26, 2007 |
| Last update posted | Jan 26, 2007 |
| Countries | Austria |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: